Evidence map›Paper›PMID 27815500›Full record

ArticleThe Journal of biological chemistry2016

A Hidden Active Site in the Potential Drug Target Mycobacterium tuberculosis dUTPase Is Accessible through Small Amplitude Protein Conformational Changes.

Anna Lopata, Ibolya Leveles, Ábris Ádám Bendes, Béla Viskolcz, Beáta G Vértessy, Balázs Jójárt, Judit Tóth

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeting a critical step in fungal hexosamine biosynthesis.The Journal of biological chemistry · 2020
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Anna LopataFrom the Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary H1117.
Ibolya LevelesFrom the Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary H1117.
Ábris Ádám BendesFrom the Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary H1117.
Béla Viskolczthe Institute of Chemistry, University of Miskolc, Miskolc, Hungary H3529.
Beáta G VértessyFrom the Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary H1117.
Balázs JójártDepartment of Chemical Informatics, University of Szeged, Szeged, Hungary H6725.
Judit TóthFrom the Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary H1117, toth.judit@ttk.mta.hu.
Hungarian Academy of Sciences · HUInstitute of Molecular Life Sciences · HUHUN-REN Research Centre for Natural Sciences · HUUniversity of Miskolc · HUUniversity of Szeged · HU

Funding

Mycobacterium tuberculosis dUTPase as a tool in disease controlR01TW008130 · FIC · HUN-REN TERMESZETTUDOMANYI KUTATOKOZPONT · PI TOTH, JUDIT · 2008 to 2012
$252k
FIC NIH HHS R01 TW008130
6 · The paper itself

Abstract

dUTPases catalyze the hydrolysis of dUTP into dUMP and pyrophosphate to maintain the proper nucleotide pool for DNA metabolism. Recent evidence suggests that dUTPases may also represent a selective drug target in mycobacteria because of the crucial role of these enzymes in maintaining DNA integrity. Nucleotide-hydrolyzing enzymes typically harbor a buried ligand-binding pocket at interdomain or intersubunit clefts, facilitating proper solvent shielding for the catalyzed reaction. The mechanism by which substrate binds this hidden pocket and product is released in dUTPases is unresolved because of conflicting crystallographic and spectroscopic data. We sought to resolve this conflict by using a combination of random acceleration molecular dynamics (RAMD) methodology and structural and biochemical methods to study the dUTPase from Mycobacterium tuberculosis In particular, the RAMD approach used in this study provided invaluable insights into the nucleotide dissociation process that reconciles all previous experimental observations. Specifically, our data suggest that nucleotide binding takes place as a small stretch of amino acids transiently slides away and partially uncovers the active site. The in silico data further revealed a new dUTPase conformation on the pathway to a relatively open active site. To probe this model, we developed the Trp

Indexed as

Molecular Dynamics SimulationBacterial ProteinsCatalytic DomainMycobacterium tuberculosisPyrophosphatasesBacterial ProteinsdUTP pyrophosphatasePyrophosphatasesdUTPasemolecular dynamicsmolecular modelingMycobacterium tuberculosisnucleotidepre-steady-state kineticssolvent accessibilitysubstrate bindingX-ray crystallography

Identifiers

PMID27815500
PMCPMC5159494
OpenAlexW2548167937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.